GTR 119955693
Tenders Are Invited For Pharmaceutical Products – Open-House-Rabattverträge 2026-19 Adalimumab
ICB — International Competitive Bid
Closes Dec 31, 2028
Western Europe
Tender Information
GTR Reference
119955693
Tendering Authority
Subscribe to view
Tender No
748796-2026
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Pharmaceutical Products – Open-House-Rabattverträge 2026-19 Adalimumab
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Western Europe
Political Region
European Union,G20
Last Date of Bid Submission
31-12-2028
Work Detail
Pharmaceutical Products – Open-House-Rabattverträge 2026-19 Adalimumab. The Health Insurance Companies Pursue The Goal Of Concluding Discount Agreements With All Suitable Pharmaceutical Companies In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients, Combinations Of Active Ingredients Or Dosage Forms, Potencies Or Finished Medicinal Products Specified In The Respective Lot. The Following Active Ingredients, Combinations Of Active Ingredients Or Dosage Forms, Potencies Or Finished Medicinal Products Are Part Of The Present Process (For Details, See The Information In The Respective Lot Titles): Adalimumab
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
7114a4a7-a25a-4d44-a428-f477431e1762.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.
Tell us about your Product / Services,
We will Find Tenders for you
